EP2923688
Samstæða til að auðvelda notanda lyfjaendurgerð
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
25.8.2011EP published:
22.3.2017EP application number:
15164909.2
EP translation filed:
22.5.2017Grant published:
15.6.2017EPO information:
European Patent Register
Max expiry date:
24.8.2031Expiry date:
24.8.2026Next due date:
31.8.2026
Title:
ASSEMBLY TO FACILITATE USER RECONSTITUTION
Timeline
Today
25.8.2011EP application
22.3.2017EP Publication
22.5.2017Translation submitted
15.6.2017Registration published
24.8.2026Expires
Owner
Name:
Takeda Pharmaceutical Company LimitedAddress:
1-1, Doshomachi 4-chome, Chuo-ku, Osaka-shi, Osaka, JP
Inventor
Name:
Houghton, Frederick Charles llAddress:
Moorpark, CA California, US
Name:
Roush, Daniel E.Address:
Niles, IL Illinois, US
Name:
Ariagno, ScottAddress:
Palatine, IL Illinois, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
376912 PDate:
25.8.2010Country:
US
Classification
Categories:
A61J 1/20
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 1.8.2017
Expires: 24.8.2018
Payer: Sigurjónsson & Thor ehf.
Number: 8
Paid: 19.7.2018
Expires: 24.8.2019
Payer: PATICE, Ólafur Ragnarsson, hrl.
Number: 9
Paid: 23.7.2019
Expires: 24.8.2020
Payer: PATICE, Ólafur Ragnarsson, hrl.
Number: 10
Paid: 21.7.2020
Expires: 24.8.2021
Payer: Patice ehf.
Number: 11
Paid: 20.7.2021
Expires: 24.8.2022
Payer: Patice ehf.
Number: 12
Paid: 20.7.2022
Expires: 24.8.2023
Payer: Patice ehf.
Number: 13
Paid: 20.7.2023
Expires: 24.8.2024
Payer: Árnason Faktor ehf.
Number: 14
Paid: 23.7.2024
Expires: 24.8.2025
Payer: Árnason Faktor ehf.
Number: 15
Paid: 12.8.2025
Expires: 24.8.2026
Payer: Árnason Faktor ehf.